Research Library

The American food supply chain is at risk due to increased farmworker shortages. This new brief explains the issues and suggests policy options to meet the needs of, and for, these vital workers.

Hostile immigration enforcement policies and anti-immigrant actions against refugees and asylum seekers are causing trauma to migrant families and exposing them to dangerous living conditions on both sides of the U.S.-Mexico border.

Despite the frozen status of Israeli-Palestinian negotiations and the considerable obstacles to restart them, a U.S.-led effort could help to gradually forge a “Framework Agreement for an Israeli-Palestinian Permanent Peace.” This policy brief outlines the principles that such a framework might embody, with the essential objective of two states for two peoples.

Effective drug policy requires acceptance that, for better or worse, licit and illicit drug use is part of our world. The authors recommend several steps the federal government can take to facilitate more pragmatic and effective drug policy at all levels of government.

The authors assert that the time is ripe for the United States and Europe to take the lead on shepherding a systems-level change in the recycling market, strengthened by government regulation and legislation. They examine the economic, social, and environmental impacts of mismanaged waste and argue that the Covid-19 pandemic could serve as a catalyst for action toward a global, circular economy.

Science, technology, and innovation are vital to America’s economy and workforce, and the competitiveness of U.S. industry. The authors offer five recommendations to ensure the establishment of an effective White House Office of Science and Technology Policy.

There is broad consensus in the medical and scientific community that substance abuse should be treated as a medical and public health problem, not a crime. The authors recommend a sensible pivot from failed policies of drug prohibition toward a realistic approach to drug use.

The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.